三级淋巴结构与肿瘤相关巨噬细胞在肝癌中的研究进展
Research Progress of Tertiary Lymphoid Structure and Tumor-Associated Macrophages in Hepatocellular Carcinoma
DOI: 10.12677/ACM.2022.122157, PDF,    国家自然科学基金支持
作者: 雷鑫焌, 张天辰, 李建辉, 聂 耶, 王彦芳, 毛珍珍：西安医学院，陕西 西安；空军军医大学第一附属医院肝胆外科，陕西 西安；宋文杰：空军军医大学第一附属医院肝胆外科，陕西 西安
关键词: 肝细胞肝癌；三级淋巴结构；肿瘤微环境；肿瘤相关巨噬细胞；Hepatocellular Carcinoma； Tertiary Lymphoid Structure； Tumor Microenvironment； Tumor-Associated Macrophages
摘要: 三级淋巴结构(TLS)是位于非典型淋巴器官部位的异位淋巴组织，以应对慢性和进行性炎症过程，如感染、移植物排斥反应、自身免疫性疾病和癌症等。在炎症驱动型癌症肝细胞肝癌(HCC)中发现了成熟程度不同的TLS。其由各种类型的免疫细胞组成，包括树突状细胞和抗原特异性B淋巴细胞和T淋巴细胞，以及巨噬细胞等，它们共同驱动针对肿瘤发展和进展的免疫反应。本篇综述旨在总结迄今为止TLS在HCC预后方面的矛盾的研究现状，试分析这种差异性结果出现的原因，以及肿瘤相关巨噬细胞(TAMs)在其中扮演的角色，为进一步的研究提供新的视角。
Abstract: Tertiary lymphoid structure (TLS) is the ectopic lymphoid tissue located in atypical lymphoid organs to deal with chronic and progressive inflammatory processes such as infection, graft rejection, autoimmune diseases and cancer. TLS with varying degrees of maturity has been found in inflammation-driven cancer hepatocellular carcinoma (HCC). It is composed of various types of immune cells, including dendritic cells and antigen-specific B lymphocytes and T lymphocytes, as well as macrophages, etc., which together drive the immune response against tumor development and progression. This review aims to summarize the contradictory research status of TLS in the prognosis of HCC so far, and tries to analyze the reasons for the emergence of such differential results, and the role of tumor-associated macrophages (TAMs) in it, so as to provide a new perspective for further research.
文章引用：雷鑫焌, 张天辰, 李建辉, 聂耶, 王彦芳, 毛珍珍, 宋文杰. 三级淋巴结构与肿瘤相关巨噬细胞在肝癌中的研究进展[J]. 临床医学进展, 2022, 12(2): 1067-1073. https://doi.org/10.12677/ACM.2022.122157

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Singal, A.G., Lampertico, P. and Nahon, P. (2020) Epidemiology and Surveillance for Hepatocellular Carcinoma: New Trends. Journal of Hepatology, 72, 250-261. [Google Scholar] [CrossRef] [PubMed]
[3] Tian, Z., Hou, X., Liu, W., Han, Z. and Wei, L. (2019) Macrophages and Hepatocellular Carcinoma. Cell & Bioscience, 9, Article No. 79. [Google Scholar] [CrossRef] [PubMed]
[4] Hernandez-Gea, V., Toffanin, S., Friedman, S.L. and Llovet, J.M. (2013) Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma. Gastroenterology, 144, 512-527. [Google Scholar] [CrossRef] [PubMed]
[5] Hou, X.J., Ye, F., Li, X.Y., Liu, W.T., Jing, Y.Y., Han, Z.P., et al. (2018) Immune Response Involved in Liver Damage and the Activation of Hepatic Progenitor Cells during Liver Tumorigenesis. Cellular Immunology, 326, 52-59. [Google Scholar] [CrossRef] [PubMed]
[6] Dieu-Nosjean, M.C., Giraldo, N.A., Kaplon, H., Germain, C., Fridman, W.H. and Sautès-Fridman, C. (2016) Tertiary Lymphoid Structures, Drivers of the Anti-Tumor Responses in Human Cancers. Immunological Reviews, 271, 260-275. [Google Scholar] [CrossRef] [PubMed]
[7] Ostuni, R., Kratochvill, F., Murray, P.J. and Natoli, G. (2015) Macrophages and Cancer: From Mechanisms to Therapeutic Implications. Trends in Immunology, 36, 229-239. [Google Scholar] [CrossRef] [PubMed]
[8] Jacquelot, N., Tellier, J., Nutt, S. and Belz, G. (2021) Tertiary Lymphoid Structures and B Lymphocytes in Cancer Prognosis and response to Immunotherapies. Oncoimmunology, 10, Article ID: 1900508. [Google Scholar] [CrossRef] 
[9] Buckley, C., Barone, F., Nayar, S., Bénézech, C. and Caamaño, J. (2015) Stromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation. Annual Review of Immunology, 33, 715-745. [Google Scholar] [CrossRef] [PubMed]
[10] Barone, F., Gardner, D.H., Nayar, S., Steinthal, N., Buckley, C.D. and Luther, S.A. (2016) Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation. Frontiers in Immunology, 7, Article No. 477. [Google Scholar] [CrossRef] [PubMed]
[11] Sautes-Fridman, C., Petitprez, F., Calderaro, J. and Fridman, W.H. (2019) Tertiary Lymphoid Structures in the Era of Cancer Immunotherapy. Nature Reviews Cancer, 19, 307-325. [Google Scholar] [CrossRef] [PubMed]
[12] Gago da Graca, C., van Baarsen, L.G.M. and Mebius, R.E. (2021) Tertiary Lymphoid Structures: Diversity in Their Development, Composition, and Role. Journal of Immunology, 206, 273-281. [Google Scholar] [CrossRef] [PubMed]
[13] Siliņa, K., Soltermann, A., Attar, F.M., Casanova, R., Uckeley, Z.M., Thut, H., et al. (2018) Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. Cancer Research, 78, 1308-1320. [Google Scholar] [CrossRef] 
[14] Posch, F., Silina, K., Leibl, S., Mündlein, A., Moch, H., Siebenhüner, A., et al. (2018) Maturation of Tertiary Lymphoid Structures and Recurrence of Stage II and III Colorectal Cancer. OncoImmunology, 7, e1378844. [Google Scholar] [CrossRef] 
[15] Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., et al. (2014) Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer. American Journal of Respiratory and Critical Care Medicine, 189, 832-844. [Google Scholar] [CrossRef] 
[16] Domblides, C., Rochefort, J., Riffard, C., Panouillot, M. and Lescaille G. (2021) Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation. Frontiers in Immunology, 12, Article ID: 698604. [Google Scholar] [CrossRef] [PubMed]
[17] Finkin, S., Taniguchi, K., Weber, A., Unger, K., et al. (2015) Ectopic Lymphoid Structures Function as Microniches for Tumor Progenitor Cells in Hepatocellular Carcinoma. Nature Immunology, 16, 1235-1244. [Google Scholar] [CrossRef] [PubMed]
[18] Calderaro, J., Petitprez, F., Becht, E., Laurent, A., Hirsch, T.Z., Rousseau, B., et al. (2019) Intra-Tumoral Tertiary Lymphoid Structures Are Associated with a Low Risk of Early Recurrence of Hepatocellular Carcinoma. Journal of Hepatology, 70, 58-65. [Google Scholar] [CrossRef] [PubMed]
[19] Li, H., Wang, J., Liu, H., Lan, T., Xu, L., Wang, G., et al. (2020) Existence of Intratumoral Tertiary Lymphoid Structures Is Associated with Immune Cells Infiltration and Predicts Better Prognosis in Early-Stage Hepatocellular Carcinoma. Aging, 12, 3451-3472. [Google Scholar] [CrossRef] [PubMed]
[20] Li, H., Liu, H., Fu, H., Li, J., Xu, L., Wang, G., et al. (2021) Peritumoral Tertiary Lymphoid Structures Correlate with Protective Immunity and Improved Prognosis in Patients with Hepatocellular Carcinoma. Frontiers in Immunology, 12, Article ID: 648812. [Google Scholar] [CrossRef] [PubMed]
[21] Martinet, L., Garrido, I., Filleron, T., Le Guellec, S., Bellard, E., Fournie, J.J., et al. (2011) Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer. Cancer Research, 71, 5678-5687. [Google Scholar] [CrossRef] 
[22] Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., et al. (2009) Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome. Cancer Research, 69, 2000-2009. [Google Scholar] [CrossRef] 
[23] Sofopoulos, M., Fortis, S.P., Vaxevanis, C.K., Sotiriadou, N.N., Arnogiannaki, N., Ardavanis, A., et al., (2019) The Prognostic Significance of Peritumoral Tertiary Lymphoid Structures in Breast Cancer. Cancer Immunology, Immunotherapy, 68, 1733-1745. [Google Scholar] [CrossRef] [PubMed]
[24] Krenkel, O. and Tacke, F. (2017) Liver Macrophages in Tissue Homeostasis and Disease. Nature Reviews Immunolog, 17, 306-321. [Google Scholar] [CrossRef] [PubMed]
[25] Scott, C.L., Zheng, F., De Baetselier, P., Martens, L., Saeys, Y., De Prijck, S., et al. (2016) Bone Marrow-Derived Monocytes Give Rise to Self-Renewing and Fully Differentiated Kupffer Cells. Nature Communications, 7, Article No. 10321. [Google Scholar] [CrossRef] [PubMed]
[26] Okabe, Y. and Medzhitov, R. (2016) Tissue Biology Perspective on Macrophages. Nature Immunology, 17, 9-17. [Google Scholar] [CrossRef] [PubMed]
[27] Sica, A., Erreni, M., Allavena, P. and Porta, C. (2015) Macrophage Polarization in Pathology. Cellular and Molecular life Sciences, 72, 4111-4126. [Google Scholar] [CrossRef] [PubMed]
[28] Chawla, A., Nguyen, K.D. and Goh, Y.P. (2011) Macrophage-Mediated Inflammation in Metabolic Disease. Nature reviews. Immunology, 11, 738-749. [Google Scholar] [CrossRef] [PubMed]
[29] Dou, L., Shi, X., He, X. and Gao, Y. (2019) Macrophage Phenotype and Function in Liver Disorder. Frontiers in Immunology, 10, Article No. 3112. [Google Scholar] [CrossRef] [PubMed]
[30] Sica, A., Invernizzi, P. and Mantovani, A. (2014) Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology. Hepatology, 59, 2034-2042. [Google Scholar] [CrossRef] [PubMed]
[31] Elliott, L.A., Doherty, G.A., Sheahan, K. and Ryan, E.J. (2017) Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity. Frontiers in Immunology, 8, Article No. 86. [Google Scholar] [CrossRef] [PubMed]
[32] Dong, P., Ma, L., Liu, L., Zhao, G., Zhang, S., Dong, L., et al. (2016) CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis. International Journal of Molecular Sciences, 17, Article No. 320. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, D., Yang, L., Yue, D., Cao, L., Li, L., Wang, D., et al. (2019) Macrophage-Derived CCL22 Promotes an Immunosuppressive Tumor Microenvironment via IL-8 in Malignant Pleural Effusion. Cancer Letters, 452, 244-253. [Google Scholar] [CrossRef] [PubMed]
[34] Ayob, A.Z. and Ramasamy, T.S. (2018) Cancer Stem Cells as Key Drivers of Tumour Progression. Journal of Biomedical Science, 25, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[35] Fan, Q.M., Jing, Y.Y., Yu, G.F., Kou, X.R., Ye, F., Gao, L., et al. (2014) Tumor-Associated Macrophages Promote Cancer Stem Cell-Like Properties via Transforming Growth Factor-Beta1-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Cancer Letters, 352, 160-168. [Google Scholar] [CrossRef] [PubMed]
[36] Thorsson, V., Gibbs, D.L., Brown, S.D., Wolf, D., Bortone, D.S., Ou Yang, T.H., et al. (2019) The Immune Landscape of Cancer. Immunity, 51, 411-412. [Google Scholar] [CrossRef] [PubMed]
[37] Chew, V., Lai, L., Pan, L., Lim CJ., Li, J., Ong, R., et al. (2017) Delineation of an Immunosuppressive Gradient in Hepatocellular Carcinoma Using High-Dimensional Proteomic and Transcriptomic Analyses. Proceedings of the National Academy of Sciences of the United States of America, 114, E5900-E5909. [Google Scholar] [CrossRef] [PubMed]
[38] Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., et al. (2014) Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells. Gastroenterology, 147, 1393-1404. [Google Scholar] [CrossRef] [PubMed]
[39] 史婉婉, 周子珍, 谭康安, 邵晨, 洪源, 肝细胞癌相关三级淋巴样结构免疫细胞组成[J]. 中国肝脏病杂志(电子版) , 2021, 13(1): 39-45.
[40] Ni, C., Yang, L., Xu, Q., Yuan, H., Wang, W., Xia, W., et al. (2019) CD68- and CD163-Positive Tumor Infiltrating Macrophages in Non-Metastatic Breast Cancer: A Retrospective Study and Meta-Analysis. Journal of Cancer, 10, 4463-4472. [Google Scholar] [CrossRef] [PubMed]
[41] Su, Y., Zhou, Y., Sun, Y.J., Wang, Y.L., Yin, J.Y., Huang, Y.J., et al. (2019) Macrophage-Derived CCL18 Promotes Osteosarcoma Proliferation and Migration by Upregulating the Expression of UCA1. Journal of Molecular Medicine, 97, 49-61. [Google Scholar] [CrossRef] [PubMed]
[42] Biswas, S.K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., et al. (2006) A Distinct and Unique Transcriptional Program Expressed by Tumor-Associated Macrophages (Defective NF-κB and Enhanced IRF-3/STAT1 Activation). Blood, 107, 2112-2122. [Google Scholar] [CrossRef] [PubMed]

为你推荐